Diamyd Medical’s rights issue oversubscribed
Diamyd Medical (Nasdaq Stockholm First North, DMYD B) today announced that the Company has completed a new share issue with preferential rights for existing shareholders through which the Company will receive proceeds of MSEK 22.1 before issue expenses. There has been substantial interest in the issue. Subscription applications totaling approximately MSEK 45.8 were received, corresponding to a subscription rate of about 207 percent.94.6 percent of the rights issue was subscribed based on subscription rights. In addition, 112.3 percent of the rights issue was subscribed without the exercise